Increased Serum Soluble Urokinase Plasminogen Activator Receptor Predicts Short-Term Outcome in Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure
Serum suPAR level at baseline was associated with a 3-month mortality in HB-ACLF patients. (a) Baseline serum suPAR concentration is higher in survivors () than nonsurvivors () with hepatitis B-related acute-on-chronic liver failure. Values are expressed as range. (b) Receiver operating characteristic (ROC) curves of suPAR and MELD score at baseline in HB-ALCF patients. Serum suPAR concentration at baseline has a stronger power for predicting unfavorable outcome as suggested by area under the curve (,) than MELD score (,).
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.